MarketInOut Stock Screener Log In | Sign Up

Jeil Pharma Holdings Inc

KRX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Jeil Pharma Holdings Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization110,528 mln
Float2.08 mln
Earnings Date08/18/2025

EPS

549
Exceptional

P / E

12.23
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.69
Likely reliable

Relative Strength

32 / 100
Underperforming

Debt / Equity

0.59
Moderate leverage

Business Description

Founded in 1959 and based in Seoul, Jeil Pharma Holdings is a South Korean pharmaceutical company that produces active drug ingredients, improved formulations, and generic medicines across a wide range of therapeutic areas, including heart health, cancer, infectious diseases, and neurology. The company sells both raw pharmaceutical ingredients and finished medicines, distributing its products to customers in roughly 40 countries across Southeast Asia, Africa, and Latin America.

Key Fundamentals

EPS549
P/E12.23
ROE-3.09
RPS41,097
ROIC0.06
ROA-1.12
Interest Cover0.06
EBITDA, mln29,223
EV / EBITDA12.56
EV / EBIT26.44
Revenue, mln612,716
EV / Revenue0.60

Quote Details

Last 6,720.00
Change -60 (-0.88%)
Open 6,550.00
Volume 4,651
Turnover 31,254,720
Average Volume 4,254.67

Financial Ratios

Pre-Tax Profit Margin1
Leverage Ratio2.84
Current Ratio1.20
Price / Book0.24
Price / Tangible Book0.25
Price / Cash Flow9.32
Debt / Equity0.59
Price / Sales0.19

Financial Strength

Altman Z-Score0.95
Piotroski F-Score 6 / 9
Beneish M-Score-2.69
Price to Intrinsic Value1.08
Price to Graham Number0.51
Shiller PE Ratio0.47

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -6.67% 19 / 100   
1 Month -11.58% 40 / 100   
2 Months 2.6% 73 / 100   
6 Months -24.92% 51 / 100   
1 Year -17.95% 44 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog